Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Ginkgo Bioworks Holdings Inc (NYSE: DNA) closed the day trading at $8.56 down -3.39% from the previous closing price of $8.86. In other words, the price has decreased by -$3.39 from its previous closing price. On the day, 1.17 million shares were traded. DNA stock price reached its highest trading level at $9.48 during the session, while it also had its lowest trading level at $8.4401.
Ratios:
For a better understanding of DNA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.79 and its Current Ratio is at 5.79. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.56.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 14 ’25 when Che Austin bought 99 shares for $8.92 per share.
Che Austin bought 99 shares of DNA for $925 on Jan 13 ’25. On Jan 10 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $10.78 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 492019424 and an Enterprise Value of 295717440. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.26 while its Price-to-Book (P/B) ratio in mrq is 0.54. Its current Enterprise Value per Revenue stands at 1.357 whereas that against EBITDA is -0.562.
Stock Price History:
The Beta on a monthly basis for DNA is 1.10, which has changed by -0.8073913 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, DNA has reached a high of $64.40, while it has fallen to a 52-week low of $5.26. The 50-Day Moving Average of the stock is -5.39%, while the 200-Day Moving Average is calculated to be -46.48%.
Shares Statistics:
Over the past 3-months, DNA traded about 1.27M shares per day on average, while over the past 10 days, DNA traded about 1377890 shares per day. A total of 41.37M shares are outstanding, with a floating share count of 36.49M. Insiders hold about 33.02% of the company’s shares, while institutions hold 48.04% stake in the company. Shares short for DNA as of 1735603200 were 7374291 with a Short Ratio of 5.81, compared to 1732838400 on 7415212. Therefore, it implies a Short% of Shares Outstanding of 7374291 and a Short% of Float of 22.15.
